Skip to main content
Premium Trial:

Request an Annual Quote

Sloan-Kettering to Adopt Genomatix Gene-Regulation Software

NEW YORK, Nov. 30 (GenomeWeb News) - The Memorial Sloan-Kettering Cancer Center in New York has signed an agreement with German informatics firm Genomatix to use its GenomatixSuite database and analysis tool for gene-regulatory networks, Genomatix said today.

 

Under the terms of the agreement, Munich-based Genomatix will provide all MSKCC clinical and research staff, fellows, and students with full access to GenomatixSuite. MSKCC's bioinformatics core facility will coordinate the access, Genomatix said in a statement.

 

GenomatixSuite also contains the largest available database of real mammalian promoter DNA sequences, the company said.

 

Genomatix said it hopes to eventually expand the agreement to all researchers at the Rockefeller University and Cornell Weill Medical College, academic institutions with which MSKCC is affiliated.

 

Financial terms of the deal were not disclosed.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.